Yoshinori Ohsumi

大隅良典是一位日本细胞生物学家，他揭示了自噬的机制，即细胞降解和回收受损成分的过程。他的工作揭示了细胞如何通过清理自身来维持健康，这一基本机制与衰老、癌症和神经退行性疾病相关。大隅目前领导东京科学大学创新研究所的研究。因他的发现，他获得了2016年诺贝尔生理学或医学奖、2012年京都奖和2017年突破奖生命科学奖。他的突破来自一个简单的实验：饥饿酵母细胞并观察它们吞噬自身内容物，从而鉴定出15个自噬相关（ATG）基因。[编辑]

大隅于1945年出生在福冈，那时二战结束前半年。他在一个被稻田、溪流和山丘环绕的房子里长大，但作为一个体弱的孩子，他在战后食物匮乏时期遭受了营养不良。他母亲在生他后感染了结核病，卧床多年，最终因夏威夷的一位家庭朋友寄来的抗生素而康复。小学时，大隅收集昆虫并记忆星座，但这些只是童年的爱好。高中时，他加入了化学俱乐部，化学反应让他着迷。他于1963年进入东京大学学习化学，但很快发现这个领域缺乏吸引力，因为它已经很成熟。20世纪60年代初分子生物学的黄金时代吸引了他，于是他作为研究生加入了今堀和友的实验室。他于1967年获得理学学士学位，1974年获得理学博士学位，均来自东京大学。

1974年底，大隅移居纽约，在洛克菲勒大学担任诺贝尔奖得主杰拉尔德·M·埃德尔曼的博士后研究员。最初研究小鼠体外受精，后来转向利用酵母研究DNA复制起始，这让他接触了酵母研究。他于1977年返回日本，在东京大学担任安楽泰宏教授的研究助理。1986年被任命为讲师，1988年43岁时晋升为副教授，在等待了近20年后终于拥有了自己的小实验室。[编辑]

1988年开设自己的实验室后，大隅专注于酵母液泡的裂解功能。不久后，他利用光学和电子显微镜在酵母中发现了自噬。利用酵母系统，他对自噬缺陷突变体进行了遗传筛选。他的团队在第一次筛选中鉴定出15个对饥饿诱导自噬必需的基因，并开始克隆这些自噬相关（ATG）基因。这一发现开启了一个全新的生物学领域。1996年，他被任命为日本冈崎市国立基础生物学研究所教授。2004年，他在叶山的综合研究大学院大学兼任教授。2009年，他转为这两所机构的荣誉教授，并成为东京工业大学教授，领导细胞生物学研究单元。2012年，他获得京都基础科学奖。2015年获得加拿大盖尔德纳国际奖，随后于2016年因发现自噬机制获得诺贝尔生理学或医学奖。2017年，他获得突破奖生命科学奖。截至2026，他是东京科学大学创新研究所的教授，继续探索细胞如何自我回收。[编辑]

大隅的公众形象是一位专注、耐心且坚持不懈的科学家，他在获得国际认可前数十年一直从事基础研究。媒体报道强调了他卑微的出身、建立独立研究的艰辛，以及使用面包酵母和显微镜的实验方法的简单性。他常被描述为一个谦逊的人，让作品自己说话。没有官方或非官方的粉丝名称、粉丝文化仪式或标志性风格的记录。[编辑]

Yoshinori Ohsumi is the 55th most famous person from Japan, a standing confirmed by the iFANN Global Fame Rankings in August 2026. This placement holds steady from the previous cycle, anchoring his global profile within a specific national context rather than a broad celebrity sphere. His fame stems not from viral moments or tabloid scandals, but from the quiet, seismic shift he caused in biological science. The iFANN system tracks this influence through a lens of enduring academic impact and sustained media coverage across research communities worldwide. While pop culture icons rely on fleeting attention, Ohsumi's recognition has deepened over decades, culminating in the 2016 Nobel Prize that cemented his legacy as the man who taught cells to eat themselves.

Despite this high-level recognition, there is no organized fandom for Yoshinori Ohsumi. No formal name exists for his supporters, nor are there fan rituals, birthday campaigns, or dedicated subreddits debating his theories. The "fans" of his work are the global scientific community and the general public benefiting from medical breakthroughs, yet they operate as an audience rather than a cult following. He remains a figure of profound respect rather than adoration, with his legend built entirely on verified milestones like the discovery of autophagy genes and the dispelling of misinformation regarding fasting cures. His story is one of solitary perseverance, where the only applause comes from peer-reviewed journals and the silence of a laboratory that finally made sense of cellular decay.[编辑]

The path to Yoshinori Ohsumi's success was paved with patience and simple observations. His breakthrough experiment involved starving yeast cells of nutrients and watching them devour their own contents, a method that revealed how cells maintain health by cleaning house. This simplicity belied the decades of effort required; Ohsumi did not have his own laboratory until he was 43 years old, nearly 20 years after returning to Japan from his postdoctoral fellowship. His motivation was rooted in a childhood memory: the words 'streptomycin' and 'aureomycin' stuck in his mind, though he didn't know what they meant then. His mother's recovery from tuberculosis through newly developed antibiotics left a lasting impression, driving him to choose research based on the precept 'doing what others have not done.' There was no shortcut to his success; it required constant and persevering efforts over decades.

Legends surrounding Ohsumi focus on the rigor of his science rather than folklore. The central iconic moment remains the identification of autophagy genes in the 1990s, which fundamentally reshaped the understanding of intracellular degradation. In October 2016, the Nobel Assembly awarded him the prize solely for this work, making him the first Japanese scientist to receive the award in physiology or medicine. Recent narratives also highlight the importance of accuracy; in late 2025 and early 2026, outlets clarified that Ohsumi remained the sole recipient of the 2016 prize, debunking false claims that he recommended fasting to cure cancer or Alzheimer's disease. These stories underscore a legacy defined by verified achievement rather than myth.[编辑]

大隅的父亲义雄是九州大学的采矿工程教授，母亲名叫信。他至少有一个哥哥，在大学假期时会给他带科学书籍。大隅于1971年与同为生物学家的妻子大隅万里子结婚，两人是在东京大学研究生院学习时认识的。他们有两个儿子。没有其他家庭成员、宠物或家庭细节的公开记录。[编辑]

大隅的博士后导师是杰拉尔德·M·埃德尔曼，洛克菲勒大学的诺贝尔奖得主免疫学家。在东京大学，他作为助理教授在安楽泰宏教授指导下工作。他的研究生导师是今堀和友。在国立基础生物学研究所的合作者包括T. Yoshimori等人。他的妻子大隅万里子是同为生物学家和研究生同学。[编辑]

大隅良典在与同为生物学家的Mariko Ōsumi在东京大学读研时相识。他们于1971年结婚，育有两子。Mariko是公开记录中他已知的唯一伴侣。截至2026年，大隅仍与Mariko Ōsumi保持婚姻关系。[编辑]

iFANN currently estimates Yoshinori Ohsumi's net worth at $5 Million as of 2026. This figure represents a curated editorial assessment of his financial standing derived primarily from major scientific prizes. The 2016 Nobel Prize in Physiology or Medicine contributed approximately 8 million Swedish kronor, or about $930,000 at the time. The 2017 Breakthrough Prize in Life Sciences added $3 million to his assets, while the 2012 Kyoto Prize provided about 50 million yen, or roughly $500,000. Beyond these accolades, Ohsumi has earned a steady academic salary as a professor at the University of Tokyo, the National Institute for Basic Biology, Tokyo Institute of Technology, and currently the Institute of Science Tokyo. Additional income sources include research grants and speaking engagements. No real estate holdings or other business ventures are publicly known.[编辑]

大隅因发现自噬机制而获得2016年诺贝尔生理学或医学奖。他还获得了2012年京都基础科学奖、2015年加拿大盖尔德纳国际奖以及2017年生命科学突破奖，这些奖项均表彰他在细胞回收方面的开创性工作。[编辑]